[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ATE225355T1 - Membranen possierende second messengers - Google Patents

Membranen possierende second messengers

Info

Publication number
ATE225355T1
ATE225355T1 AT96918434T AT96918434T ATE225355T1 AT E225355 T1 ATE225355 T1 AT E225355T1 AT 96918434 T AT96918434 T AT 96918434T AT 96918434 T AT96918434 T AT 96918434T AT E225355 T1 ATE225355 T1 AT E225355T1
Authority
AT
Austria
Prior art keywords
messengers
membranes
posing
image
acyloxyalkyl esters
Prior art date
Application number
AT96918434T
Other languages
English (en)
Inventor
Roger Y Tsien
Carsten Schultz
Wenhong Li
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Application granted granted Critical
Publication of ATE225355T1 publication Critical patent/ATE225355T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals
    • C07H19/20Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/091Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/117Esters of phosphoric acids with cycloaliphatic alcohols
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4071Esters thereof the ester moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4075Esters with hydroxyalkyl compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/6552Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring
    • C07F9/65522Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring condensed with carbocyclic rings or carbocyclic ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT96918434T 1995-06-07 1996-06-07 Membranen possierende second messengers ATE225355T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/475,758 US5834436A (en) 1993-04-09 1995-06-07 Membrane-permeant second messengers
PCT/US1996/009923 WO1996040695A1 (en) 1995-06-07 1996-06-07 Membrane-permeant second messengers

Publications (1)

Publication Number Publication Date
ATE225355T1 true ATE225355T1 (de) 2002-10-15

Family

ID=23889001

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96918434T ATE225355T1 (de) 1995-06-07 1996-06-07 Membranen possierende second messengers

Country Status (8)

Country Link
US (1) US5834436A (de)
EP (1) EP0842181B1 (de)
JP (1) JPH11508240A (de)
AT (1) ATE225355T1 (de)
AU (1) AU709883B2 (de)
CA (1) CA2220994A1 (de)
DE (1) DE69624121T2 (de)
WO (1) WO1996040695A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5866548A (en) * 1993-04-09 1999-02-02 The Regents Of The University Of California Caged membrane-permeant inositol phosphates
US5955453A (en) * 1998-04-24 1999-09-21 The Regents Of The University Of California Membrane-permeant phosphoinositides
US6221856B1 (en) 1999-02-03 2001-04-24 Inologic, Inc. Inositol derivatives for inhibiting superoxide anion production
US6812342B2 (en) 2001-06-20 2004-11-02 Board Of Regents, The University Of Texas System Esters of cyclic ADP ribose derivatives
US20050181464A1 (en) * 2002-04-04 2005-08-18 Affinium Pharmaceuticals, Inc. Novel purified polypeptides from bacteria
KR100578732B1 (ko) * 2004-03-05 2006-05-12 학교법인 포항공과대학교 분자 수송체로서의 이노시톨 유도체 및 이의 제조방법
KR100849033B1 (ko) * 2006-09-07 2008-07-29 포항공과대학교 산학협력단 알디톨 또는 이노시톨 유도체를 골격으로 한 분자 수송체
EP2927209A1 (de) 2014-03-31 2015-10-07 Afinitica Technologies, S. L. Verfahren zur Herstellung von 1,1-disubstituierten äthylenischen Monomeren
EP4286369A1 (de) 2022-06-03 2023-12-06 Bostik SA Biobasierte cyanoacrylatverbindung

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4515722A (en) * 1982-03-30 1985-05-07 Merck & Co., Inc. Phosphatidyl inositol analogs useful as anti-inflammatory/analgesic agents
US4816570A (en) * 1982-11-30 1989-03-28 The Board Of Regents Of The University Of Texas System Biologically reversible phosphate and phosphonate protective groups
US4968788A (en) * 1986-04-04 1990-11-06 Board Of Regents, The University Of Texas System Biologically reversible phosphate and phosphonate protective gruops
US5428163A (en) * 1986-12-31 1995-06-27 Mills; Randell L. Prodrugs for selective drug delivery
US5053399A (en) * 1989-02-03 1991-10-01 University Of Pittsburgh Myo-inositol analogs and methods for their use
US4988682A (en) * 1989-02-03 1991-01-29 University Of Pittsburgh Myo-inositol analogs and method for their use
US5210263A (en) * 1990-05-15 1993-05-11 University Of Pittsburgh Inositol phosphate analogs and methods for their use
US5177064A (en) * 1990-07-13 1993-01-05 University Of Florida Targeted drug delivery via phosphonate derivatives
US5227508A (en) * 1992-01-24 1993-07-13 Mayo Foundation For Medical Education And Research 3-deoxy-3-substituted analogs of phosphatidylinositol
US5693521A (en) * 1993-04-09 1997-12-02 The Regents Of The University Of California Membrane-permeant second messengers

Also Published As

Publication number Publication date
DE69624121D1 (de) 2002-11-07
JPH11508240A (ja) 1999-07-21
WO1996040695A1 (en) 1996-12-19
EP0842181A4 (de) 1998-11-25
US5834436A (en) 1998-11-10
AU709883B2 (en) 1999-09-09
CA2220994A1 (en) 1996-12-19
DE69624121T2 (de) 2003-06-18
AU6109996A (en) 1996-12-30
EP0842181A1 (de) 1998-05-20
EP0842181B1 (de) 2002-10-02

Similar Documents

Publication Publication Date Title
ES8802522A1 (es) Un procedimiento para preparar nuevos derivados macrociclicos de lactona
EP0215654A3 (en) Macrolide antibiotics and their preparation
AU589686B2 (en) Intermediates for the production of amino and substituted amino phosphinylalkanoyl compositions
CA2139233A1 (fr) Composes utiles comme agents edulcorants, leur procede de preparation
AU591541B2 (en) Process for the preparation of 2-arylpropionic acids
ES2131207T3 (es) Derivados de amidas del acido valproico y 2-valproenoico y su uso como anticonvulsivos.
AU573294B2 (en) 11-beta-arylestradienes
ES2164184T3 (es) Esteres de poliaspartato hiperramificados y procedimiento para su preparacion.
AU1066988A (en) New 11-aryl steroid derivatives
ATE225355T1 (de) Membranen possierende second messengers
EP1437359A3 (de) Neue 3,6-Hemiketale der 9a-Azalidklasse
DE69612374D1 (de) Derivate des carbapenem-3-carbonsäureesters
AU7509481A (en) 2-(1,4-benzodioxan-2-ylalicyl)imidazoles
KR890008134A (ko) 브라씨노스테로이드 유도체 및 식물 성장 조절제
BE893957A (fr) Steroides esterifies en la position 17 et thio-esterifies en la position 21,leur procede de preparation et leur application comme medicament.
AU549877B2 (en) Preparation of aminomethylphosphonic acid
ES2038389T3 (es) Procedimiento para la obtencion de 3-aminosidnoniminas substituidas farmacologicamente activas.
IE812843L (en) Estra-4,9-dienes
BG49444A1 (en) Acylureidoamynotiasolylni derivatives and method for their preparation
ES2145483T3 (es) Procedimiento de preparacion de derivados de arilalquinilo-n-hidroxiurea con actividad inhibidora de la lipoxigenasa.
IE812641L (en) Imidazoles
ES2144430T3 (es) Hidrolasa de ester de acido 7-amino-3-metoximetil-3-cefem-4-carboxilico, procedimiento para su preparacion, asi como su empleo.
JPS6440057A (en) Covering material for skin

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties